Back to top
more

UnitedHealth Group (UNH)

(Delayed Data from NYSE)

$400.96 USD

400.96
11,895,648

+1.43 (0.36%)

Updated Jun 18, 2026 04:00 PM ET

After-Market: $400.40 -0.56 (-0.14%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.00%
2Buy18.14%
3Hold10.18%
4Sell5.72%
5Strong Sell3.11%
S&P50011.49%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value F Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 17% (41 out of 247)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.

Bryan Hayes headshot

Bear of the Day: UnitedHealth Group (UNH)

by Bryan Hayes

Recent positives mask deeper structural, operational, and regulatory vulnerabilities.

Zacks Equity Research

UnitedHealth Group (UNH) Stock Drops Despite Market Gains: Important Facts to Note

by Zacks Equity Research

In the closing of the recent trading day, UnitedHealth Group (UNH) stood at $347.89, denoting a -1.31% move from the preceding trading day.

Zacks Equity Research

UnitedHealth (UNH) Is Considered a Good Investment by Brokers: Is That True?

by Zacks Equity Research

Based on the average brokerage recommendation (ABR), UnitedHealth (UNH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

Kaibalya Pravo Dey headshot

Will UnitedHealth's Push for Access to Trump Calm Investor Jitters?

by Kaibalya Pravo Dey

UNH doubles lobbying spend, reshapes legal team and seeks Trump access amid regulatory risks.

Abhinab Dasgupta headshot

Beat the Market the Zacks Way: CommScope, Micron, Oracle in Focus

by Abhinab Dasgupta

Zacks' strategies continue to outpace the market in 2025, with standout gains from CommScope, Micron, Oracle, and others across multiple model portfolios.

Kaibalya Pravo Dey headshot

Elevance Health Shrinks to Grow Stronger: From Part D to Plan B?

by Kaibalya Pravo Dey

ELV exits Part D and trims Medicare Advantage markets, betting on stronger-margin plans to protect profitability.

Moumi Mondal headshot

CVS Health Makes Headway in Stabilizing Aetna: What's Driving It?

by Moumi Mondal

CVS makes progress in stabilizing Aetna with leadership, risk management and operational changes.

Zacks Equity Research

Humana Wins TVH Assets in Bankruptcy Sale, But Cut Points Drag Shares

by Zacks Equity Research

HUM scoops up $68M Florida care centers, but star rating hurdles send shares tumbling 12%. Can HUM turn risk into reward?

Zacks Equity Research

The Zacks Analyst Blog Highlights Nebius, Microsoft, UnitedHealth, Apple and Oracle

by Zacks Equity Research

Nebius, Microsoft, UnitedHealth, Apple, and Oracle drive market buzz as AI deals, Medicare gains, and cloud growth shake up stocks.

Kaibalya Pravo Dey headshot

UnitedHealth Finds Its Stars, Soars 8.6% as Humana Trips on Cut Points

by Kaibalya Pravo Dey

UNH surges 8.6% as it projects stable Medicare Advantage star ratings, easing investor worries over performance.